Medical Science in Iran

*Iran-Made Coronavirus Vaccine 93.5% Efficient*

Head of the COV-Iran Barekat vaccine project at the Headquarters for the Ex*****on of Imam Khomeini's Order (HEIKO) Hassan Jalili announced on Wednesday that the vaccine has proved 93.5% efficiency against coronavirus.

“The results of the first (human trial) phase of the vaccine showed that it is safe and the results of the second phase on a group of people aged 18 to 75 years old showed that the blood serum of the vaccinated people has 93.5% ability to neutralize the coronavirus,” Jalili said.

He added that *COV-Iran* Barekat is also efficient on the British mutation, noting that the vaccine will be injected to the Iranian people across the country soon.

“We are also preparing the required documents for the World Health Organization, but the final documents will be sent when the data of the third phase of our clinical trial is completed, so at the moment we are preparing the data of the phases one and two at the request of the WHO. We will report the results to the WHO when the third phase is complete,” Jalili said.

He also added that 12 countries, including Asian, South American and one European country, have filed request to import COV-Iran Barekat from Iran.